Candela Begins Worldwide Shipment of Smoothbeam; A Revolutionary Diode Laser for Skin Renewal
WAYLAND, Mass.--(BW HealthWire)--April 3, 2001--
New Technology Promises to Become Standard of Treatment for Millions
of Baby Boomers
Candela Corporation (NASDAQ:CLZR) is pleased to report the first shipments of Smoothbeam, its newly introduced diode-based skin renewal laser. Prior to shipping, the Smoothbeam laser already received necessary national and international safety approvals and certifications including UL for the United States, CE for Europe, CSA for Canada, and CB scheme which is accepted in over 39 countries.
Gerard E. Puorro, Candela's President and CEO, commented: "This shipment of a significant number of Smoothbeams is the first milestone in the sales history of this laser. Its immediate, enthusiastic acceptance by physicians reinforces our premise that the market was looking for a skin renewal laser that was smaller, lighter, more affordable, and easier to use than what was previously available. We expect the Smoothbeam to lead the market by filling an important role in the physician's aesthetic laser capability."
David J. Goldberg, M.D., Director of Laser Research in the Department of Dermatology at New York's Mt. Sinai School of Medicine, and Principal Investigator for Smoothbeam clinical trials, reported: "This laser is doing exactly what we want. It's an elegant method for improving skin with minimal patient downtime. Patients will be pleased with this quick and easy option for skin care."
Dr. Goldberg went on to explain: "In sun-damaged or aging skin, the collagen in the dermis is irregular and haphazard. Clinically, we see it as skin that has lost its tone and texture. The unique 1450 nm wavelength of the Smoothbeam is absorbed by water in the damaged collagen. It heats that water in the damaged collagen inducing a mild thermal injury. This leads the body to create new collagen that has better direction -- it's thicker, and it leads to better tone and quality of the skin."
About Candela: Candela Corporation develops, manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using aesthetic laser systems and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 50 countries from offices in the United States, Europe, and Asia. Candela established the aesthetic laser market 12 years ago, and currently has an installed base of over 4,000 lasers worldwide. Candela is an Equal Opportunity and Affirmative Action Employer, M/F/H/V. For more about Candela, visit the company's web site at www.clzr.com.
Safe Harbor Statement: Except for the historical information contained herein, this news release contains forward-looking statements that constitute Candela's current intentions, hopes, beliefs, expectations or predictions of the future, which are, therefore, inherently subject to risks and uncertainties. Candela's actual results could differ materially from those anticipated in Candela's forward-looking statements based on various factors, including without limitation: cancellation or deferral of customer orders, total dependence on a small number of strategic distribution relationships, difficulties in the timely development and market acceptance of new products, market developments that vary from the current public expectations concerning the growth of the laser industry, increased competitive pressures, or changes in economic conditions. Further information on factors that could affect Candela's performance is included in Candela's periodic reports filed with the SEC, including but not limited to, Candela's Form 10-K (or any amendment thereto) for the year ended July 1, 2000, and subsequent Forms 10-Q. Candela cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Candela expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Candela's expectations or any change in events, conditions or circumstance on which any such statement is based.
CONTACT:
Candela Corporation
Jane Smith
508-358-7400, x247 |
